Next Level: Method of Levels for Psychosis

Next Level: Evaluating the feasibility and acceptability of Method of Levels therapy for people experiencing a first episode of psychosis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN13359355

Enrollment

Registered

2016-09-12

Start date

2016-09-15

Completion date

Unknown

Last updated

2022-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Specialty: Mental Health, Primary sub-specialty: Psychosis

Interventions

Participants will be randomly allocated to either treatment as usual (TAU) or TAU plus Method of Levels (MOL) therapy. The online Sealed Envelope programme will be used to randomise participants to on

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. People aged 16-65 years 2. Current user of Greater Manchester West Mental Health NHS Foundation Trust Early Intervention Services (assessed as experiencing a first episode of psychosis) 3. Sufficient English language abilities (verbal and written) to complete written material (for example, outcome measures) and participate in psychological therapy

Exclusion criteria

Exclusion criteria: 1. People aged under 16 2. Not currently using of Greater Manchester West Mental Health NHS Foundation Trust Early Intervention Services. 3. Literacy or English language difficulties that make it difficult for the person to complete written material (for example, outcome measures) or to participate in psychological therapy 4. GMW Early Intervention service users who are currently serving a custodial prison

Design outcomes

Primary

Measure	Time frame
1. Recruitment rate is measured using the number of participants consenting to participate in the trial at baseline 2. Retention rate is measured using the number of participants retained in the triil at 14 month follow up	—

Secondary

Measure	Time frame
1. Subjective well-being, symptoms, functioning and risk are measured using the CORE-OM at baseline, 10 months and 14 months 2. The problems troubling participants most are measured using the Psychological Outcome Profiles (PSYCHLOPS) at baseline, 10 months and 14 months 3. Reorganisation of goal conflict is measured using the Reorganisation of Conflict Scale (ROC) at baseline, each therapy session, 10 months and 14 months 4. Personal recovery from psychosis is measured using the Questionnaire about the Process of Recovery (QPR) at baseline, 10 months and 14 months 5. Individual, social, relational, and overall functioning are measured using the Outcome Rating Scale (ORS) at baseline, each therapy session, 10 months and 14 months 6. Participant’s perceptions of the therapeutic alliance are measured using the Session Rating Scale (SRS) at each therapy session	—

Measure

Time frame

1. Subjective well-being, symptoms, functioning and risk are measured using the CORE-OM at baseline, 10 months and 14 months 2. The problems troubling participants most are measured using the Psychological Outcome Profiles (PSYCHLOPS) at baseline, 10 months and 14 months 3. Reorganisation of goal conflict is measured using the Reorganisation of Conflict Scale (ROC) at baseline, each therapy session, 10 months and 14 months 4. Personal recovery from psychosis is measured using the Questionnaire about the Process of Recovery (QPR) at baseline, 10 months and 14 months 5. Individual, social, relational, and overall functioning are measured using the Outcome Rating Scale (ORS) at baseline, each therapy session, 10 months and 14 months 6. Participant’s perceptions of the therapeutic alliance are measured using the Session Rating Scale (SRS) at each therapy session

—

Countries

England, United Kingdom

Contacts

Public ContactRobert Griffiths

robert.griffiths@gmw.nhs.uk+44 (0)161 358 1395

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 23, 2026